CN111643580B - Traditional Chinese medicine composition for treating neuromyelitis optica - Google Patents

Traditional Chinese medicine composition for treating neuromyelitis optica Download PDF

Info

Publication number
CN111643580B
CN111643580B CN202010444182.7A CN202010444182A CN111643580B CN 111643580 B CN111643580 B CN 111643580B CN 202010444182 A CN202010444182 A CN 202010444182A CN 111643580 B CN111643580 B CN 111643580B
Authority
CN
China
Prior art keywords
root
raw materials
traditional chinese
neuromyelitis optica
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010444182.7A
Other languages
Chinese (zh)
Other versions
CN111643580A (en
Inventor
陶长年
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010444182.7A priority Critical patent/CN111643580B/en
Publication of CN111643580A publication Critical patent/CN111643580A/en
Application granted granted Critical
Publication of CN111643580B publication Critical patent/CN111643580B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716—Clematis (leather flower)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533—Leonurus (motherwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/732—Chaenomeles, e.g. flowering quince
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/86—Violaceae (Violet family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicine compositions, and discloses a traditional Chinese medicine composition for treating neuromyelitis optica, which comprises the following raw materials in parts by mass: 8-12g of clematis root, 8-12g of Chinese violet, 7-9g of pawpaw, 5-8g of pangolin scales, 9-12g of achyranthes root, 8-11g of trichosanthes root, 11-13g of angelica, 10-13g of white peony root, 14-16g of motherwort, 9-12g of Chinese starjasmine stem, 9-12g of cortex acanthopanacis and 3-6g of phaseolus calcaratus. The invention provides a traditional Chinese medicine composition for treating neuromyelitis optica, which is based on patient condition and syndrome differentiation, is used for treating diseases not based on a certain prescription, but is prepared by one person, and has excellent treatment effect and low side effect.

Description

Traditional Chinese medicine composition for treating neuromyelitis optica
Technical Field
The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating neuromyelitis optica.
Background
The spinal cord is a part of the central nervous system of human and vertebrate animals, and inside the vertebral canal, the upper end is connected with medulla oblongata, and the two sides send out paired nerves which are distributed to four limbs, body wall and viscera. The inner part of the spinal cord is provided with an H-shaped grey nerve tissue which mainly comprises nerve cells, and the outer layer is a white nerve tissue which is composed of nerve fibers. The spinal cord is the central pivot for many simple reflexes. Myelitis is a spinal cord pathological response, and neuromyelitis optica is a response neuromyelitis optica pathological condition.
The treatment of myelitis and neuromyelitis optica are diseases without medicines in the medical field, and are a worldwide medical problem, at present, the disease development is suppressed by using hormones and antibiotics in the treatment of various hospitals, the side effects after the hormones and the antibiotics of western medicines are used are very harmful, the viscera functions are injured, the head and face are swollen and deformed seriously after the western medicines are used, after the neuromyelitis optica patients are ill, the lower limbs are cramped and numbed gradually, the patients are not conscious after being scalded by warm water, the double lower limbs are paralyzed and even paraplegic and other serious consequences are caused after the hormones and the antibiotics of western medicines are used, the paroxysmal to acute cramp and thick strip-shaped packing blocks from the lower abdomen to the groin and the legs and the feet, pain and distending pain are caused, the patients are in constant circulation day and night, the sleep is affected, the patients are very painful, the life needs to nurse, and the economic and mental burden is brought to families.
In order to solve the above problems, the present application provides a Chinese medicinal composition for treating neuromyelitis optica.
Disclosure of Invention
Objects of the invention
The invention provides a traditional Chinese medicine composition for treating neuromyelitis optica, aiming at solving the technical problems in the background technology, the invention takes the medicine according to the patient condition and the syndrome, the treatment does not depend on a certain prescription to cure the disease, but one person has one prescription, the treatment effect is excellent, and the side effect is low.
(II) technical scheme
In order to solve the problems, the invention provides a traditional Chinese medicine composition for treating neuromyelitis optica, which comprises the following raw materials in parts by mass: 8-12g of clematis root, 8-12g of Chinese violet, 7-9g of pawpaw, 5-8g of pangolin scales, 9-12g of achyranthes root, 8-11g of trichosanthes root, 11-13g of angelica, 10-13g of white peony root, 14-16g of motherwort, 9-12g of Chinese starjasmine stem, 9-12g of cortex acanthopanacis and 3-6g of phaseolus calcaratus.
Preferably, the feed additive comprises the following raw materials in percentage by mass: 8-12g of radix clematidis, 10-12g of herba violae, 7-9g of pawpaw, 5-7g of pangolin scales, 9-12g of achyranthes bidentata, 8-10g of radix trichosanthis, 11-13g of angelica sinensis, 11-13g of radix paeoniae alba, 14-16g of motherwort herb, 9-10g of Chinese starjasmine stem, 10-12g of cortex acanthopanacis and 3-6g of phaseolus calcaratus.
Preferably, the feed additive consists of the following raw materials in percentage by mass: 9-12g of clematis root, 10-12g of bunge corydalis herb, 7-9g of pawpaw, 5-8g of pangolin scales, 10-12g of achyranthes root, 8-11g of trichosanthes root, 11-12g of angelica, 10-12g of white peony root, 14-16g of motherwort, 9-11g of Chinese starjasmine stem, 9-12g of cortex acanthopanacis and 3-6g of phaseolus calcaratus.
Preferably, for severe patients, 3-6g of Pseudobulbus Cremastrae Seu pleiones can be added.
A Chinese medicinal composition for treating neuromyelitis optica is prepared from decoction by the following steps:
s1, weighing required raw materials according to a mass ratio, and putting the raw materials into a pottery jar;
s2, soaking the mixture in normal-temperature water, and turning and stirring the mixture up and down;
s3, decocting the raw materials to 145-155g, and then stopping heating to filter out liquid medicine;
s4, adding normal-temperature water again to submerge the decocted raw materials;
and S5, filtering out the liquid medicine when the concentration of decoction is similar to the concentration of the first decoction, and mixing the liquid medicine with the first filtered liquid medicine until the total amount is 280-320g.
Preferably, in S2, the amount of cold water is based on the level of the medicine.
Preferably, in S2, the soaking time is 40 minutes.
Preferably, the raw materials can be processed into pills for eating.
The technical scheme of the invention has the following beneficial technical effects:
has the advantages of taking the medicine according to the patient's condition and dialectical condition, good treatment effect and low side effect because the treatment does not depend on a certain prescription but only one person for one prescription.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention will be described in further detail with reference to specific embodiments. It is to be understood that these descriptions are only illustrative and are not intended to limit the scope of the present invention. Moreover, in the following description, descriptions of well-known structures and techniques are omitted so as to not unnecessarily obscure the concepts of the present invention.
Example 1
The invention provides a traditional Chinese medicine composition for treating neuromyelitis optica, which comprises the following raw materials in parts by mass: 10g of clematis root, 10g of Chinese violet, 8g of pawpaw, 6g of pangolin, 10g of achyranthes root, 10g of trichosanthes root, 12g of angelica, 12g of white peony root, 15g of motherwort, 10g of Chinese starjasmine stem, 10g of cortex acanthopanacis and 3g of phaseolus calcaratus.
In an alternative embodiment, 5g of Pseudobulbus Cremastrae Seu pleiones can be added for patients with severe disease.
A Chinese medicinal composition for treating neuromyelitis optica is prepared from decoction by the following steps:
s1, weighing required raw materials according to a mass ratio, and putting the raw materials into a pottery jar;
s2, soaking the mixture in normal-temperature water, and turning and stirring the mixture up and down;
s3, decocting the raw materials to 150g, and then stopping heating to filter out liquid medicine;
s4, adding normal-temperature water again to submerge the decocted raw materials;
and S5, filtering out the liquid medicine when the concentration of the decoction is close to the concentration of the first decoction, and mixing the liquid medicine with the first filtered liquid medicine until the total amount is 300g.
It should be noted that it is administered 20 minutes before breakfast and supper, and is administered with medicine for syndrome differentiation at later stage.
In an alternative embodiment, in S2, the amount of cold water is based on the level of the drug.
In an alternative embodiment, in S2, the soaking time is 40 minutes.
In an alternative embodiment, the raw materials may be processed for consumption as pellets.
It should be noted that the dosage is taken three times a day.
Example 2
A traditional Chinese medicine composition for treating neuromyelitis optica is prepared from the following raw materials in parts by mass: 9g of clematis root, 11g of bunge corydalis herb, 8g of pawpaw, 6g of pangolin, 11g of achyranthes root, 8g of trichosanthes root, 12g of angelica, 12g of white peony root, 15g of motherwort, 9g of Chinese starjasmine stem, 12g of cortex acanthopanacis and 6g of phaseolus calcaratus.
In an alternative embodiment, 4g of Pseudobulbus Cremastrae Seu pleiones can be added for patients with severe disease.
A Chinese medicinal composition for treating neuromyelitis optica is prepared from decoction by the following steps:
s1, weighing required raw materials according to a mass ratio, and putting the raw materials into a pottery jar;
s2, soaking the mixture in normal-temperature water, and turning and stirring the mixture up and down;
s3, decocting the raw materials to 145g, and then stopping heating to filter out liquid medicine;
s4, adding normal-temperature water again to submerge the decocted raw materials;
and S5, filtering out the liquid medicine when the concentration of decoction is similar to the concentration of the first decoction, and mixing the liquid medicine with the first filtered liquid medicine until the total amount is 280g.
It should be noted that it is administered 20 minutes before breakfast and supper, and is administered with medicine for syndrome differentiation at later stage.
In an alternative embodiment, in S2, the amount of cold water is based on the level of the drug.
In an alternative embodiment, in S2, the soaking time is 40 minutes.
In an alternative embodiment, the raw materials may be processed for consumption as pellets.
It should be noted that the dosage is taken three times a day.
Example 3
A traditional Chinese medicine composition for treating neuromyelitis optica is prepared from the following raw materials in parts by mass: 12g of clematis root, 10g of Chinese violet, 8g of pawpaw, 5g of pangolin, 10g of achyranthes root, 11g of trichosanthes root, 11g of angelica, 12g of white peony root, 14g of motherwort, 10g of Chinese starjasmine stem, 10g of cortex acanthopanacis and 5g of phaseolus calcaratus.
In an alternative embodiment, 5g of Pseudobulbus Cremastrae Seu pleiones can be added for patients with severe disease.
A Chinese medicinal composition for treating neuromyelitis optica is prepared from decoction by the following steps:
s1, weighing required raw materials according to a mass ratio, and putting the raw materials into a pottery jar;
s2, soaking in normal-temperature water, and turning and stirring uniformly up and down;
s3, decocting the raw materials to 150g, and then stopping heating to filter out liquid medicine;
s4, adding normal-temperature water again to submerge the decocted raw materials;
and S5, filtering out the liquid medicine when the concentration of the decoction is close to the concentration of the first decoction, and mixing the liquid medicine with the first filtered liquid medicine until the total amount is 295g.
It should be noted that it is administered 20 minutes before breakfast and supper, and is administered with medicine for syndrome differentiation at later stage.
In an alternative embodiment, in S2, the amount of cold water is based on the level of the drug.
In an alternative embodiment, in S2, the soaking time is 40 minutes.
In an alternative embodiment, the raw materials may be processed for consumption as pellets.
It should be noted that the dosage is taken three times a day.
Application example: a patient with certain money, a woman in more than 50 years old, a farmer in a certain town of a certain area in the state city, who suffers from neuromyelitis optica in 2019 and stays in a hospital in the state city, is treated by adding antibiotics to a conventional hormone prednisone acetate tablet in western medicine, and is treated by a hospital in the city, the curative effect is poor, the disease condition gradually worsens, after the medicine is taken for resisting the disease, the head and face swelling and serious deformation stop, the abdomen of the patient to the leg and foot part suddenly tear the tendon, the abdomen of the patient refers to a thick and long bag and has a plurality of parts, the patient can pull obliquely and straightly after two or three minutes, the patient also has a slight breathing sound feeling, is alive and cannot die, the patient can walk after two months, the phenomenon of tendon pulling and pain of the abdomen and the leg and foot part is avoided, and the sequelae are recovered, and the family work can be done.
It is to be understood that the above-described embodiments of the present invention are merely illustrative of or explaining the principles of the invention and are not to be construed as limiting the invention. Therefore, any modification, equivalent replacement, improvement and the like made without departing from the spirit and scope of the present invention should be included in the protection scope of the present invention. Further, it is intended that the appended claims cover all such variations and modifications as fall within the scope and boundaries of the appended claims or the equivalents of such scope and boundaries.

Claims (8)

1. A traditional Chinese medicine composition for treating neuromyelitis optica is characterized by being prepared from the following raw materials in parts by mass: 8-12g of radix clematidis, 8-12g of bunge corydalis herb, 7-9g of pawpaw, 5-8g of pangolin scales, 9-12g of achyranthes root, 8-11g of trichosanthes root, 11-13g of angelica, 10-13g of white peony root, 14-16g of motherwort, 9-12g of Chinese starjasmine stem, 9-12g of cortex acanthopanacis and 3-6g of phaseolus calcaratus.
2. The traditional Chinese medicine composition for treating neuromyelitis optica according to claim 1, which is prepared from the following raw materials in parts by mass: 8-12g of radix clematidis, 10-12g of bunge corydalis herb, 7-9g of pawpaw, 5-7g of pangolin scales, 9-12g of achyranthes root, 8-10g of trichosanthes root, 11-13g of angelica, 11-13g of white peony root, 14-16g of motherwort, 9-10g of Chinese starjasmine stem, 10-12g of cortex acanthopanacis and 3-6g of phaseolus calcaratus.
3. The traditional Chinese medicine composition for treating neuromyelitis optica according to claim 1, which is prepared from the following raw materials in parts by mass: 9-12g of radix clematidis, 10-12g of bunge corydalis herb, 7-9g of pawpaw, 5-8g of pangolin scales, 10-12g of achyranthes root, 8-11g of trichosanthes root, 11-12g of angelica, 10-12g of white peony root, 14-16g of motherwort, 9-11g of Chinese starjasmine stem, 9-12g of cortex acanthopanacis and 3-6g of phaseolus calcaratus.
4. A traditional Chinese medicine composition for treating neuromyelitis optica is characterized by being prepared from the following raw materials in parts by mass: 8-12g of clematis root, 8-12g of bunge corydalis herb, 7-9g of pawpaw, 5-8g of pangolin scales, 9-12g of achyranthes root, 8-11g of trichosanthes root, 11-13g of angelica, 10-13g of white peony root, 14-16g of motherwort, 9-12g of Chinese starjasmine stem, 9-12g of cortex acanthopanacis, 3-6g of phaseolus calcaratus and 3-6g of edible tulip.
5. The preparation method of the traditional Chinese medicine composition for treating neuromyelitis optica of any one of claims 1 to 4, wherein the traditional Chinese medicine composition is prepared into decoction, and the preparation method comprises the following specific steps:
s1, weighing required raw materials according to a mass ratio, and putting the raw materials into a pottery jar;
s2, soaking the mixture in normal-temperature water, and turning and stirring the mixture up and down;
s3, decocting the mixed solution of the soaked traditional Chinese medicine composition to 145-155g, and then stopping heating to filter out liquid medicine;
s4, adding normal-temperature water again to submerge the decocted raw materials;
and S5, filtering out the liquid medicine when the concentration of decoction is similar to the concentration of the first decoction, and mixing the liquid medicine with the first filtered liquid medicine until the total amount is 280-320g.
6. The method for preparing a Chinese medicinal composition for treating neuromyelitis optica according to claim 5, wherein in S2, the amount of water at normal temperature is based on the level of the medicinal powder.
7. The method for preparing a Chinese medicinal composition for treating neuromyelitis optica according to claim 5, wherein the soaking time in S2 is 40 minutes.
8. The traditional Chinese medicine composition for treating neuromyelitis optica according to any one of claims 1 to 4, wherein the raw materials are processed into pills for eating.
CN202010444182.7A 2020-05-22 2020-05-22 Traditional Chinese medicine composition for treating neuromyelitis optica Active CN111643580B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010444182.7A CN111643580B (en) 2020-05-22 2020-05-22 Traditional Chinese medicine composition for treating neuromyelitis optica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010444182.7A CN111643580B (en) 2020-05-22 2020-05-22 Traditional Chinese medicine composition for treating neuromyelitis optica

Publications (2)

Publication Number Publication Date
CN111643580A CN111643580A (en) 2020-09-11
CN111643580B true CN111643580B (en) 2022-11-22

Family

ID=72342634

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010444182.7A Active CN111643580B (en) 2020-05-22 2020-05-22 Traditional Chinese medicine composition for treating neuromyelitis optica

Country Status (1)

Country Link
CN (1) CN111643580B (en)

Also Published As

Publication number Publication date
CN111643580A (en) 2020-09-11

Similar Documents

Publication Publication Date Title
CN1061854C (en) Medicinal preparation for treatment and prevention of gynopathy
CN103705641A (en) Traditional Chinese medicine composition for treating oligospermia and asthenozoospermia
CN104758844A (en) Traditional Chinese medicine for treating premature ovarian failure
CN101912536B (en) Medicinal composition for treating rheumatism and rheumatoid disease
CN110974925A (en) Thyroid nodule preparation and preparation method thereof
CN111643580B (en) Traditional Chinese medicine composition for treating neuromyelitis optica
CN105288116A (en) Traditional Chinese medicine composition for treating schizophrenia
CN104758607A (en) Traditional Chinese medicine composition for treating premature ovarian failure
CN103251754A (en) Traditional Chinese medicine composition for treating bedsore
CN105250526A (en) Traditional Chinese medicine composition for treating schizophrenia
CN102125612B (en) Chinese medicinal preparation for treating acute lumbar sprain
CN102614375B (en) Traditional Chinese medicine compound for tonifying kidney, strengthening yang and treating impotence and preparing method thereof
CN101843759B (en) Oral Chinese medicament for treating fracture
CN105617112A (en) Traditional Chinese medicine composition for treating functional uterine bleeding
CN105832885A (en) Traditional Chinese medicine composition for treating insomnia
CN104840624A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN105902983A (en) Chinese medicinal preparation for treating wind-cold-wetness arthralgia
CN103933270A (en) Traditional Chinese medicine preparation for treating infant nocturnal enuresis
CN105770834B (en) A kind of Chinese medicinal pill for treating polymyalgia rheumatica
CN105148050A (en) Traditional Chinese medicinal composition for treating kidney stone
CN105232642A (en) Traditional Chinese medicine combination capable of promoting fracture healing
CN103720986A (en) Traditional Chinese medicine composition for treating leukorrhea
CN111760028A (en) Composition of main monarch drug in pharmaceutical prescription for treating tumor
CN103251851B (en) Internal and external traditional Chinese medicine formulation for treating rheumatic and rheumatoid diseases
CN117959375A (en) Traditional Chinese medicine composition for warming muscles and cold dampness between meridians

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant